Structure Of Oral Mucosa, Oro-Mucosal Drug Application Routes, and Drug Forms

Pandey GS, Pandey AN. Critical review on buccal mucoadhesive drug delivery systems.

Bartlett JA, van der Voort Maarschalk K. Understanding the oral mucosal absorption and resulting clinical pharmacokinetics of asenapine. Aaps pharmscitech. 2012;13:1110-5.

Alyami HS, Ibrahim MA, Alyami MH, Dahmash EZ, Almeanazel OT, Algahtani TS, et al. Formulation of sublingual promethazine hydrochloride tablets for rapid relief of motion sickness. Saudi Pharmaceutical Journal. 2021;29(5):478-86.

Dawes C. Gland size estimation and body mass index improve salivary flow rate assessment. Archives of oral biology. 2007;52(5):409-10.

Chiappin S, Antonelli G, Gatti R, Elio F. Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clinica chimica acta. 2007;383(1-2):30-40.

Madhav NS, Shakya AK, Shakya P, Singh K. Orotransmucosal drug delivery systems: a review. Journal of controlled release. 2009;140(1):2-11.

Khan AB, Kingsley T, Caroline P. Sublingual tablets and the benefits of the sublingual route of administration. Journal of Pharmaceutical Research. 2017;16(3):257-67.

Lee J, Lww SK, Choi YW. The effect of storage conditions on the permeability of porcine buccal mucosa. Archives of pharmacal research. 2002;25:546-9.

Hooda R, Tripathi M, Kapoor K. A review on oral mucosal drug delivery system. The pharma innovation. 2012;1(1).

SHANKAR U, MADHAV S. A smart oro-soft palate mucosal drug delivery: Credentials and future trends. Marmara Pharmaceutical Journal. 2015;19(3):208-21.

Zhang H, Zhang J, Streisand JB. Oral mucosal drug delivery: clinical pharmacokinetics and therapeutic applications. Clinical pharmacokinetics. 2002;41:661-80.

Narang N, Sharma J. Sublingual mucosa as a route for systemic drug delivery. Int J Pharm Pharm Sci. 2011;3(Suppl 2):18-22.

Bertram U, Bodmeier R. In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form. European journal of pharmaceutical sciences. 2006;27(1):62-71.

Varshosaz J. Insulin delivery systems for controlling diabetes. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery. 2007;1(1):25-40.

Bhati R, Nagrajan RK. A detailed review on oral mucosal drug delivery system. International Journal of Pharmaceutical Sciences and Research. 2012;3(3):659.

Motlekar NA, Youan B-BC. The quest for non-invasive delivery of bioactive macromolecules: a focus on heparins. Journal of controlled release. 2006;113(2):91-101.

Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Advanced drug delivery reviews. 2002;54(5):675-93.

Di Colo G, Zambito Y, Zaino C. Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues. Journal of pharmaceutical sciences. 2008;97(5):1652-80.

de Vries ME, Bodde H, Verhoef J, Junginger H. Developments in buccal drug delivery. Critical reviews in therapeutic drug carrier systems. 1991;8(3):271-303.

Jacobsen J, Christrup LL, Jensen N-H. Medicated chewing gum: Pros and Cons. American journal of drug delivery. 2004;2:75-88.

Streisand JB, Zhang J, Niu S, McJames S, Natte R, Pace NL. Buccal absorption of fentanyl is pH-dependent in dogs. The Journal of the American Society of Anesthesiologists. 1995;82(3):759-64.

Goldstein-Dresner MC, Davis PJ, Kretchman E, Siewers RD, Certo N, Cook DR. Double-blind comparison of oral transmucosal fentanyl citrate with oral meperidine, diazepam, and atropine as preanesthetic medication in children with congenital heart disease. Anesthesiology. 1991;74(1):28-33.

Satheesh N, Shankar MU. A Smart Flexiplate for Oral Transmucosal Soft Palatal Delivery of Amikacin—Proceedings of the International world PSWC 2007. Held in April. 2007:22-3.

Satheesh N, Shankar MU. A novel oro-soft palatal platform for transmucosal gentamicin delivery. Proceedings of ICSS held at Jadavpur University on 13th February. 2008;2008.

Hua S. Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration. Frontiers in pharmacology. 2019;10:1328.

Wang Z, Chow MS. Overview and appraisal of the current concept and technologies for improvement of sublingual drug delivery. Therapeutic delivery. 2014;5(7):807-16.

De Jesús Valle MJ, Zarzuelo Castañeda A, Maderuelo C, Cencerrado Treviño A, Loureiro J, Coutinho P, et al. Development of a mucoadhesive vehicle based on lyophilized liposomes for drug delivery through the sublingual mucosa. Pharmaceutics. 2022;14(7):1497.

Allen LV, Popovich NG, Ansel HC. Pharmaceutical dosage forms and drug delivery systems. Delhi, India: BI Pubication. 2005;8:265.

Lindert S, Breitkreutz J. Oromucosal multilayer films for tailor-made, controlled drug delivery. Expert opinion on drug delivery. 2017;14(11):1265-79.

Lai KL, Fang Y, Han H, Li Q, Zhang S, Li HY, et al. Orally-dissolving film for sublingual and buccal delivery of ropinirole. Colloids and Surfaces B: Biointerfaces. 2018;163:9-18.

Kumar RS, Chandra TS. Sublingual drug delivery systems-faster therapeutic action dosage forms. Journal of Drug Delivery and Therapeutics. 2019;9(4-A):838-41.

Thulluru A, Mahammed N, Madhavi C, Nandini K, Sirisha S, Spandana D. Sublingual Tablets-An Updated Review. Asian Journal of Pharmaceutical Research. 2019;9(2):97-103.

Mizrahi B, Domb AJ. Mucoadhesive polymers for delivery of drugs to the oral cavity. Recent patents on drug delivery & formulation. 2008;2(2):108-19.

He S, Mu H. Microenvironmental pH Modification in Buccal/Sublingual Dosage Forms for Systemic Drug Delivery. Pharmaceutics. 2023;15(2):637.

Heller J. Penhale, Use of bioerodible polymers. self-Regulated Drug Delivery Systems PIL, Controlled Release Technology PA. 1997;76:281-2.

Sudhakar Y, Kuotsu K, Bandyopadhyay A. Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs. Journal of controlled release. 2006;114(1):15-40.

Şenel S, Rathbone MJ, Cansız M, Pather I. Recent developments in buccal and sublingual delivery systems. Expert opinion on drug delivery. 2012;9(6):615-28.

Jain AK, Chalasani KB, Khar RK, Ahmed FJ, Diwan PV. Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery. Journal of drug targeting. 2007;15(6):417-27.

Morales JO, Brayden DJ. Buccal delivery of small molecules and biologics: of mucoadhesive polymers, films, and nanoparticles. Current opinion in pharmacology. 2017;36:22-8.

Hua S, De Matos MB, Metselaar JM, Storm G. Current trends and challenges in the clinical translation of nanoparticulate nanomedicines: pathways for translational development and commercialization. Frontiers in pharmacology. 2018;9:790.

Hua S. Lipid-based nano-delivery systems for skin delivery of drugs and bioactives. Frontiers Media SA; 2015. p. 219.

Wang YY, Lai SK, Suk JS, Pace A, Cone R, Hanes J. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that “slip” through the human mucus barrier. Angewandte Chemie. 2008;120(50):9872-5.

Mašek J, Lubasova D, Lukáč R, Turanek-Knotigova P, Kulich P, Plockova J, et al. Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles-important step towards effective mucosal vaccines. Journal of Controlled Release. 2017;249:183-95.

Teubl BJ, Meindl C, Eitzlmayr A, Zimmer A, Fröhlich E, Roblegg E. In‐vitro permeability of neutral polystyrene particles via buccal mucosa. Small. 2013;9(3):457-66.

Holpuch AS, Hummel GJ, Tong M, Seghi GA, Pei P, Ma P, et al. Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies. Pharmaceutical research. 2010;27:1224-36.

Roblegg E, Fröhlich E, Meindl C, Teubl B, Zaversky M, Zimmer A. Evaluation of a physiological in vitro system to study the transport of nanoparticles through the buccal mucosa. Nanotoxicology. 2012;6(4):399-413.

Mouftah S, Abdel-Mottaleb MM, Lamprecht A. Buccal delivery of low molecular weight heparin by cationic polymethacrylate nanoparticles. International journal of pharmaceutics. 2016;515(1-2):565-74.

Xu Y, Zhang X, Zhang Y, Ye J, Wang H-L, Xia X, et al. Mechanisms of deformable nanovesicles based on insulin-phospholipid complex for enhancing buccal delivery of insulin. International Journal of Nanomedicine. 2018;13:7319.

Hua S, Marks E, Schneider JJ, Keely S. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine: nanotechnology, biology and medicine. 2015;11(5):1117-32.

Scholz OA, Wolff A, Schumacher A, Giannola LI, Campisi G, Ciach T, et al. Drug delivery from the oral cavity: focus on a novel mechatronic delivery device. Drug discovery today. 2008;13(5-6):247-53.

Giannola LI, De Caro V, Giandalia G, Siragusa MG, Campisi G, Florena AM, et al. Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features. European journal of pharmaceutics and biopharmaceutics. 2007;65(2):238-46.

Ciper M, Bodmeier R. Modified conventional hard gelatin capsules as fast disintegrating dosage form in the oral cavity. European journal of pharmaceutics and biopharmaceutics. 2006;62(2):178-84.

Tallury P, Alimohammadi N, Kalachandra S. Poly (ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate. dental materials. 2007;23(4):404-9.